Gabapentin
Product Images NDC 53002-1538

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 53002-1538). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Image 01)

This is a table that shows the mean pain score for two different treatments, Parkod and Gabapentin, over the course of several weeks. The pain score for the placebo treatment is also shown. The table has two periods: a four-week dose titration period and a six-week fixed dose period. The data for the baseline and weeks is available.*

FDA Label Image

Figure 2 (Image 02)

This appears to be a chart or graph displaying the mean pain score for individuals who received a placebo or varying doses of Gabapentin during a 4-week fixed dose period. The x-axis represents the weeks of the study, while the y-axis represents the pain score. The doses of Gabapentin administered were 1800 mg/day and 2400 mg/day. The graph shows a decrease in mean pain score over the course of the study for all groups, with the 2400 mg/day group generally experiencing the lowest pain scores.*

FDA Label Image

Figure 3 (Image 03)

FDA Label Image

Image-04 (Image 04)

FDA Label Image

Gabapentin Structural Formula (Image 05)

FDA Label Image

Image-09 (Image 09)

FDA Label Image

Label Image (Lbl530021538)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.